Zacks Research Decreases Earnings Estimates for AstraZeneca

AstraZeneca PLC (NASDAQ:AZN – Free Report) – Analysts at Zacks Research lowered their Q1 2026 earnings estimates for shares of AstraZeneca in a report released on Thursday, June 12th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $1.14 for the quarter, down from their prior forecast of […]

Leave a Reply

Your email address will not be published.

Previous post Raymond James Forecasts Reduced Earnings for Gold Royalty
Next post Q2 EPS Estimate for CenterPoint Energy Decreased by Analyst